Burgess D. Daniel's most recent trade in Cidara Therapeutics Inc was a trade of 20,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 20,500 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 11,100 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 2,125 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 2,125 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 1,400 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 875 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 875 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 550 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 550 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 550 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 450 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Sale or transfer of securities back to the company at price $ 221.50 per share. | 07 Jan 2026 | 150 | 0 (0%) | 0% | 221.5 | 33,225 | Common Stock |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 11,100 | 11,100 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Burgess D. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 20,500 | 20,500 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 2,125 | 2,125 | - | - | Stock Option (right to buy) | |
| Arbutus Biopharma Corp | Daniel D. Burgess | Director | 23 May 2024 | 67,000 | 67,000 | - | - | Stock Option (Right to Buy) | ||
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 42,500 | 42,500 | - | - | Stock Option (right to buy) | |
| Arbutus Biopharma Corp | Daniel D. Burgess | Director | 24 May 2023 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | ||
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | |
| Arbutus Biopharma Corp | Daniel D. Burgess | Director | 25 May 2022 | 41,000 | 41,000 | - | - | Stock Option (Right to Buy) | ||
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Arbutus Biopharma Corp | Daniel D. Burgess | Director | 03 Jun 2021 | 22,000 | 22,000 | - | - | Stock Options |